Additionally, we discovered a potential therapeutic target, THBS1, which, combined with conventional anti-TB chemotherapy, may be a promising adjuvant therapy for alleviating fibrosis outcomes and improving organ function in TB patients. The gene discussed is THBS1; the disease is tuberculosis.